Ochre Bio YC 申请

Winter 2020Active

Ochre Bio 在 Winter 2020 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Winter 2020
行业: HealthcareTherapeutics
团队规模: 50
状态: Active
已发布: 2020

创始人

Quin WillsFounder/CSO

Ochre Bio 做什么

Ochre Bio is a biotechnology company developing RNA medicines for chronic liver diseases.

Ochre Bio 的 YC 申请，重建版

Y Combinator 申请

Ochre Bio，Winter 2020 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

Ochre Bio

Describe what your company does in 50 characters or less.

RNA medicines for liver diseases

What is your company going to make? Please describe your product and what it does or will do.

We create RNA-based medicines targeting chronic liver diseases. Our product uses RNA therapies to modulate gene expression specifically in the liver, aiming to address conditions where there are no effective treatments today.

Where do you live now, and where would the company be based after YC?

We live in Oxford, England, United Kingdom and plan to keep the company based here after YC.

Explain your decision regarding location.

Our deep expertise and initial research foundation are in Oxford, surrounded by leading biotech research and a growing life sciences community. Staying here gives us access to talent and resources critical to developing RNA therapies for liver diseases.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 Ochre Bio 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 Ochre Bio 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Ochre Bio 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

Ochre Bio 是哪个 YC 批次的？

Ochre Bio 是 Y Combinator Winter 2020 批次的成员。

谁创立了 Ochre Bio？

Ochre Bio 由 Quin Wills 创立。

Ochre Bio 做什么？